title: Development of MicroRNA Therapeutics for Hepatocellular Carcinoma.
abstract: Hepatocellular carcinoma (HCC) is the most common form of liver cancer and is the third leading cause of cancer-related deaths worldwide. Treatment options for HCC are very limited, as it is often diagnosed at a late stage. Recent studies have demonstrated that microRNAs (miRNAs), a class of non-coding RNAs, are aberrantly expressed in HCC. Some of these were shown to be functionally involved in carcinogenesis and tumor progression, suggesting that miRNAs can serve as novel molecular targets for HCC therapy. Several promising studies have recently demonstrated the therapeutic potential of miRNAs in animal models and in reducing the viral load in hepatitis C patients. In this review, these advances and strategies for modulating miRNAs for in vivo therapeutic delivery and replacement therapy are discussed.
authors.affiliation: Department of Radiology, University of Minnesota Medical School, MMC 292 Mayo Memorial Building, 420 Delaware Street S.E., Minneapolis, MN 55455, USA. arava001@umn.edu.
authors.forename: Rajagopal N
authors.initials: RN
authors.lastname: Aravalli
keywords: animal model; liver cancer; microRNA; replacement therapy
references.citation: Nucleic Acids Res. 2009 Feb;37(3):e24
references.pmid: 19136465
references.citation: J Biol Chem. 2011 Oct 21;286(42):36677-85
references.pmid: 21878637
references.citation: Cancer Res. 2011 Aug 1;71(15):5214-24
references.pmid: 21690566
references.citation: World J Gastroenterol. 2005 Dec 21;11(47):7391-400
references.pmid: 16437707
references.citation: Cancer Res. 2007 Jul 1;67(13):6092-9
references.pmid: 17616664
references.citation: Am J Pathol. 2008 Sep;173(3):856-64
references.pmid: 18688024
references.citation: Cancer Gene Ther. 2010 Jun;17(6):398-408
references.pmid: 20094072
references.citation: Hepatology. 2012 Sep;56(3):1025-33
references.pmid: 22473819
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
references.pmid: 14973191
references.citation: PLoS One. 2012;7(4):e35331
references.pmid: 22496917
references.citation: Nat Rev Cancer. 2011 Aug 05;11(9):644-56
references.pmid: 21822212
references.citation: Cancer Res. 2011 Feb 15;71(4):1442-53
references.pmid: 21169410
references.citation: Cancer Res. 2010 Jul 15;70(14):5923-30
references.pmid: 20570894
references.citation: Hepatology. 2009 Apr;49(4):1098-112
references.pmid: 19173277
references.citation: Semin Oncol. 2011 Dec;38(6):752-63
references.pmid: 22082761
references.citation: Biochem Biophys Res Commun. 2011 Nov 4;414(4):675-80
references.pmid: 21982769
references.citation: Mol Ther. 2010 Sep;18(9):1650-6
references.pmid: 20606648
references.citation: J Cell Biol. 2012 Oct 29;199(3):407-12
references.pmid: 23109665
references.citation: Nat Methods. 2007 Sep;4(9):721-6
references.pmid: 17694064
references.citation: Cancer Res. 2008 Jul 1;68(13):5049-58
references.pmid: 18593903
references.citation: Gene Ther. 2012 Apr;19(4):411-7
references.pmid: 21850051
references.citation: Br J Cancer. 2011 Jan 18;104(2):235-40
references.pmid: 21102580
references.citation: Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12177-82
references.pmid: 16091473
references.citation: Dig Liver Dis. 2010 Jul;42 Suppl 3:S206-14
references.pmid: 20547305
references.citation: Nat Methods. 2009 Jan;6(1):63-6
references.pmid: 19043411
references.citation: Cancer Res. 2010 Sep 15;70(18):7027-30
references.pmid: 20807816
references.citation: Clin Dev Immunol. 2012;2012:980250
references.pmid: 22474489
references.citation: Nucleic Acids Res. 2008 Mar;36(4):1153-62
references.pmid: 18158304
references.citation: Biomaterials. 2013 Jan;34(4):1354-63
references.pmid: 23146432
references.citation: Nat Genet. 2011 Mar 20;43(4):371-8
references.pmid: 21423181
references.citation: AAPS J. 2007 Mar 23;9(1):E92-104
references.pmid: 17408239
references.citation: Biomaterials. 2012 Feb;33(5):1462-76
references.pmid: 22098779
references.citation: J Cell Biochem. 2006 Oct 15;99(3):671-8
references.pmid: 16924677
references.citation: Carcinogenesis. 2011 Nov;32(11):1641-7
references.pmid: 21890460
references.citation: Front Genet. 2012 Jul 02;3:120
references.pmid: 22783274
references.citation: Hepatology. 2010 May;51(5):1614-23
references.pmid: 20209605
references.citation: PLoS One. 2008 May 21;3(5):e2236
references.pmid: 18493594
references.citation: Anticancer Agents Med Chem. 2011 Jul;11(6):500-21
references.pmid: 21554203
references.citation: J Biol Chem. 2008 May 9;283(19):13205-15
references.pmid: 18319255
references.citation: Int J Cancer. 2011 Jan 15;128(2):412-7
references.pmid: 20309940
references.citation: Mol Syst Biol. 2010 Aug 24;6:402
references.pmid: 20739924
references.citation: Hepatology. 2011 Dec;54(6):2137-48
references.pmid: 21809363
references.citation: Angew Chem Int Ed Engl. 2008;47(39):7482-4
references.pmid: 18712719
references.citation: Hepatology. 2010 Mar;51(3):846-56
references.pmid: 20054866
references.citation: PLoS One. 2008;3(12):e4029
references.pmid: 19107213
references.citation: Oncogene. 2012 Jul 12;31(28):3357-69
references.pmid: 22056881
references.citation: Carcinogenesis. 2008 Nov;29(11):2126-31
references.pmid: 18711148
references.citation: FEBS Lett. 2012 Mar 23;586(6):884-91
references.pmid: 22449976
references.citation: Oncogene. 2010 Mar 25;29(12):1787-97
references.pmid: 20023698
references.citation: Int J Cancer. 2008 Oct 1;123(7):1616-22
references.pmid: 18649363
references.citation: Hepatol Res. 2009 Aug;39(8):786-94
references.pmid: 19473441
references.citation: Cancer Lett. 2009 Mar 8;275(1):44-53
references.pmid: 19006648
references.citation: Target Oncol. 2012 Dec;7(4):217-25
references.pmid: 23179556
references.citation: Hepatology. 2008 Jun;47(6):1955-63
references.pmid: 18433021
references.citation: Hepatology. 2009 Aug;50(2):490-9
references.pmid: 19472311
references.citation: Nucleic Acids Symp Ser (Oxf). 2008;(52):71-2
references.pmid: 18776258
references.citation: Carcinogenesis. 2010 May;31(5):766-76
references.pmid: 19843643
references.citation: J Hepatol. 2012 Jun;56(6):1371-83
references.pmid: 22314424
references.citation: Mol Cancer Ther. 2008 Oct;7(10 ):3129-40
references.pmid: 18852116
references.citation: Gene Ther. 2011 Dec;18(12):1121-6
references.pmid: 21633392
references.citation: Carcinogenesis. 2012 May;33(5):1113-20
references.pmid: 22362728
references.citation: Clin Cancer Res. 2009 Aug 15;15(16):5073-81
references.pmid: 19671867
references.citation: Nat Biotechnol. 2011 Feb;29(2):129-33
references.pmid: 21301436
references.citation: J Pathol. 2012 Jul;227(3):275-85
references.pmid: 22262409
references.citation: Biomaterials. 2012 Jan;33(1):207-17
references.pmid: 21944470
references.citation: Hepatology. 2009 May;49(5):1571-82
references.pmid: 19296470
references.citation: Nucleic Acids Res. 2006 May 11;34(8):2294-304
references.pmid: 16690972
references.citation: Oncogene. 2008 Sep 25;27(43):5651-61
references.pmid: 18521080
references.citation: Drug Discov Today. 2013 Mar;18(5-6):282-9
references.pmid: 23064097
references.citation: Science. 2010 Jan 8;327(5962):198-201
references.pmid: 19965718
references.citation: Hepatology. 2011 Dec;54(6):2064-75
references.pmid: 22144109
references.citation: Gastroenterology. 2007 Aug;133(2):647-58
references.pmid: 17681183
references.citation: Pharm Res. 2011 Dec;28(12 ):3091-100
references.pmid: 21853360
references.citation: Mol Ther. 2011 Jun;19(6):1123-30
references.pmid: 21427707
references.citation: Semin Cancer Biol. 2008 Apr;18(2):89-102
references.pmid: 18295505
references.citation: Nature. 2005 Dec 1;438(7068):685-9
references.pmid: 16258535
references.citation: Cell. 2012 Apr 27;149(3):515-24
references.pmid: 22541426
references.citation: Blood. 2011 Dec 22;118(26):6881-92
references.pmid: 22042699
references.citation: Cell. 2009 Jun 12;137(6):1005-17
references.pmid: 19524505
references.citation: Hepatology. 2011 Nov;54(5):1729-40
references.pmid: 21793034
references.citation: RNA Biol. 2012 Feb;9(2):137-42
references.pmid: 22258222
references.citation: Oncogene. 2006 Apr 20;25(17):2537-45
references.pmid: 16331254
references.citation: Biomaterials. 2012 Feb;33(6):1838-50
references.pmid: 22142769
references.citation: Arch Toxicol. 2013 Feb;87(2):227-47
references.pmid: 23007558
references.citation: Cancer Lett. 2011 Nov 28;310(2):160-9
references.pmid: 21802841
references.citation: Cancer Res. 2010 Jun 15;70(12):5184-93
references.pmid: 20501828
references.citation: Oncol Rep. 2011 Nov;26(5):1281-6
references.pmid: 21725618
references.citation: Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15472-7
references.pmid: 17875987
references.citation: Biochem Biophys Res Commun. 2008 Oct 24;375(3):315-20
references.pmid: 18692484
references.citation: FASEB J. 2012 Jul;26(7):3032-41
references.pmid: 22459148
references.citation: Cancer Biol Ther. 2009 Sep;8(18):1686-93
references.pmid: 19901517
references.citation: Pharm Res. 2011 Dec;28(12):2996-3015
references.pmid: 22033880
references.citation: Gastroenterology. 2008 Jul;135(1):257-69
references.pmid: 18555017
references.citation: Mol Ther. 2011 Jun;19(6):1116-22
references.pmid: 21427705
references.citation: Mutat Res. 2008 Feb 1;638(1-2):205-9
references.pmid: 17900631
references.citation: Eur J Cancer. 2011 Aug;47(12):1789-97
references.pmid: 21612914
references.citation: Nat Rev Drug Discov. 2006 Oct;5(10):835-44
references.pmid: 17016424
references.citation: J Cell Mol Med. 2008 Dec;12(6A):2189-204
references.pmid: 19120703
references.citation: Cell Metab. 2006 Feb;3(2):87-98
references.pmid: 16459310
references.citation: J Control Release. 2012 Apr 30;159(2):240-50
references.pmid: 22285547
references.citation: Cancer Res. 2006 Dec 15;66(24):11851-8
references.pmid: 17178882
references.citation: Gene Ther. 2011 Dec;18(12):1104-10
references.pmid: 21525952
references.citation: World J Biol Chem. 2010 Apr 26;1(4):41-54
references.pmid: 21537368
references.citation: Nat Biotechnol. 2009 Jun;27(6):549-55
references.pmid: 19465925
references.citation: Clin Cancer Res. 2010 Feb 1;16(3):867-75
references.pmid: 20103675
references.citation: Expert Opin Biol Ther. 2007 Jul;7(7):1021-34
references.pmid: 17665991
references.citation: Cancer Invest. 2012 Oct;30(8):577-82
references.pmid: 22812695
references.citation: Cancer Res. 2009 Feb 1;69(3):1135-42
references.pmid: 19155302
references.citation: Nat Rev Drug Discov. 2010 Oct;9(10):775-89
references.pmid: 20885409
references.citation: Biotechnol Prog. 2007 Mar-Apr;23(2):423-9
references.pmid: 17286384
references.citation: Nature. 2006 May 25;441(7092):537-41
references.pmid: 16724069
references.citation: Pharm Res. 2011 Dec;28(12):3030-42
references.pmid: 21879389
references.citation: Nat Rev Genet. 2003 May;4(5):346-58
references.pmid: 12728277
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D152-7
references.pmid: 21037258
references.citation: J Gastroenterol Hepatol. 2011 Mar;26(3):437-49
references.pmid: 21332540
references.citation: FEBS Lett. 2012 Jul 30;586(16):2396-403
references.pmid: 22684007
references.citation: Oncol Rep. 2012 Aug;28(2):701-6
references.pmid: 22664953